Paracetamol

Mrs. Jones is an 89 year-old woman who migrated to Australia from Germany 40 years ago. Since the passing of her husband two years ago, Amaile’s health has begun to slowly deteriorate obliging her to leave her active lifestyle. This Essay will discuss a Care Plan for Mrs. Jones focusing on two care priorities, Pain assessment and management and Potential impact on ADL performance. This discussion will be constructed around the processes identified within the Levett-Jones Clinical reasoning cycle

I have had the pleasure of planning an activity within my placement. My placement is based within an NHS hospital where they provide therapeutic interventions for adults who have learning disabilities, complex needs and a forensic background. The therapeutic intervention that I have planned, is to assist Stacey to travel independently to various locations within Dundee using public transport. Whilst this is the main aim of the therapeutic intervention, it is hoped that whilst this intervention is

1.1 The following legislation governs the use of medication in a care setting: The Medicines Act 1968 The Misuse of Drugs Act 1971 The Misuse of Drugs (Safe Custody) Regulations 1973 The Health and Safety at Work Act (1974) COSHH The Mental Capacity Act (2005) The Access to health records Act (1990) The Data Protection Act (1998) 1.2 The Medicines Act 1968 and Prescription Only Medicines (Human Use) Order 1997 cover the sale, use and production of medicines. The Medicines and Healthcare Products

Within this assignment it is intended to present an example of a prescribing situation that arose in practice, to ensure prescribing issues are illustrated. The rationale for the decisions reached will also be discussed. A brief overview of the nurse prescribing initiative and how it developed will be addressed. The importance of ethical principles, accountability and legal issues that surround nurse prescribing will be demonstrated. As a patient will be addressed in the example, a pseudonym will

As mentioned in class, as well as in the Krishna (2008) article, the drug development and approval process is an extensive and costly endeavor. The goal of experimental medicine is to increase the efficiency of drug development by providing a better understanding of the drug’s mechanism(s) of action, dose response, efficacy, and safety, allowing the process to be accelerated for the most promising and efficacious candidates (Krishna, Herman, & Wagner, 2008). Preclinical testing begins with identifying

Mumps is an enveloped single stranded, non-segmented, negative-sense RNA virus belonging to the Paramyxoviridae family. The Mump virus genome is a 15.3-kb RNA with seven contiguous transcription units, encoding the nucleocapsid-associated protein (NP), V protein (V)/phosphoprotein (P), matrix (M) protein, fusion (F) protein, small hydrophobic (SH) protein, hemagglutinin-neuraminidase (HN) protein, and large (L) protein (Choi, 2010). Mumps was a common worldwide childhood disease dating back to

Miss Brightman has been diasgnosed with asthma. Her current medication includes a short-acting beta2 agonist, when required, as well as a regularly inhaled corticosteroid. By referring to the BNF, this places Miss Brightman at step 2 on the asthma step therapy chart. Miss Brightman’s asthma is currently not controlled, and there are several viable courses of action to consider that could reverse this. One option would be to progress Miss Brightman onto step 3; a long-acting beta2 agonist would be

Assessment Task One Mrs Barbara Green Introduction Nursing care to the old is an initiative that has been less emphasized on in the nursing career. Recently it has become quite significant that as one age, one develops the propensity to illnesses. While taking care of these elderly patients, not all nurses can manage the task since not every nurse learnt these type skills in school. The duty requires a specialist nurse who has enough skills as well as compassion and understanding. The need

As mentioned in class, as well as in the Krishna (2008) article, the drug development and approval process is an extensive and costly endeavor. The goal of experimental medicine is to increase the efficiency of drug development by providing a better understanding of the drug’s mechanism(s) of action, dose response, efficacy, and safety, allowing the process to be accelerated for the most promising and efficacious candidates (Krishna, Herman, & Wagner, 2008). Preclinical testing begins with identifying

ZIKA VIRUS EPIDEMIC – A GLOBAL CONCERN: “The level of concern is high as is the level of uncertainty,” said the World Health Organization (WHO) Director General –Dr Margaret Chan when briefing the executive board on the Zika situation in Geneva on 28th January 2016. She also mentioned four main reasons as to why the WHO is deeply concerned about the Zika situation, which include the virus’ virulence, potential for further international spread, lack of population immunity and lack of vaccines, specific